Jupiter Life Line Hospitals Ltd Q1 FY2025 Concall Summary

Key Takeaways

• Steady quarter, as expected: Q1 is seasonally weak for elective procedures, and performance matched internal plans. Occupancy rose across all three hospitals, with Pune jumping from 53% to 62% YoY.
• Indore is the growth engine: Occupancy grew ~10pp to 57% and still has headroom, plus 75 new beds are under construction. Case mix improvement will drive ARPOB for another year or two before it matures to inflation-linked growth.
• A third greenfield is in sight: Management wants to add one more hospital this financial year, with a couple of negotiations underway, though land acquisition timelines make the closing date uncertain.
• Margin target set at ~25%: Management sees this as a respectable level achievable as hospitals mature over the next three years, with no self-payer price hike planned this year.
• What to watch next quarter: Whether the new hospital negotiation closes, the pace of Indore's construction and case mix shift, and any early traction signals from the newly installed da Vinci robotic systems.

Occupancy & Volume Drivers

• Seasonality explains the quarter: Q1 and Q3 are traditionally weaker because elective work gets pushed out by vacations, doctor travel, and patients avoiding lifestyle procedures during weddings and festivals. Performance was as per expectation.
• Pune still has room: Occupancy grew from 53% to 62% YoY, with about 10 percentage points of headroom remaining. A semi-finished ICU for 12 beds still needs commissioning, and beyond that nothing more can be added at this site.
• Indore is mid-ramp: Occupancy moved from ~46-47% to 57%, with further headroom available. The 75-bed expansion has commenced construction and is expected to be ready by end of this financial year, with operations starting in early Q1 FY26.
• Thane is the cash engine: At ~70% occupancy, Thane is mature and generating cash to fund growth elsewhere. ARPOB here will now be driven only by inflation.
• Full-service model diversifies risk: All hospitals operate as community hospitals with no single branch exceeding 15% of business. Services span childbirth to transplant and oncology.

ARPOB & Case Mix

• Thane and Pune shift to inflation-linked ARPOB: Going forward, ARPOB growth at these mature hospitals will be driven only by inflation.
• Indore case mix still has runway: Complexity and frequency of complex procedures will drive Indore's ARPOB for another year or two, after which it too will slide into inflation-linked growth.
• No self-payer price hike this year: Management has no plan for a price increase currently, though it may consider one at the end of this year or the beginning of next year.

Thakker: "Indore will see this case mix driver... after that, Indore should also slide into this inflation-linked growth orbit."

Expansion Pipeline

• Indore beds under construction: Construction has commenced for about 75 additional beds, targeted for commissioning by end of FY25 and operations in early Q1 FY26.
• Dombivli progressing on plan: Construction is advancing as per schedule. Doctor engagement will begin about one quarter before operationalization.
• Second Pune hospital in regulatory stage: The application for regulatory permissions has begun. Management hopes to secure all necessary clearances in the next one or two quarters, then begin construction.
• Third greenfield being negotiated: Management wants to add one more hospital this financial year, with a couple of negotiations underway. The geographic focus remains Western India, looking at locations across Maharashtra and Gujarat.
• Long-term cadence taking shape: Dombivli will come first, then the second Pune hospital, then the year after that management hopes to launch a third new project. No second hospital is planned for Indore currently.

Thakker: "Greenfield projects mean that you have to first buy land and in India that comes with its own set of timelines. So today I can't give you a definitive answer about where it is and when it will come up."

Margins & Pricing

• ~25% is the medium-term target: Management sees around 25% as a respectable margin, achievable as hospitals mature over the next three years.
• Self-payer pricing on hold: No price hike is planned for self-payers this year. Management may revisit this at year-end or the beginning of next year.
• Mature hospitals fund the pipeline: Thane's cash generation at ~70% occupancy supports the capital needs of Indore's expansion, Dombivli's construction, and the second Pune hospital.

Thakker: "around 25% give or take something is a respectable margin according to us and that can be expected."

Clinical & Technology Investments

• Robotic surgery now across all three hospitals: Da Vinci robotic systems have been installed in all three hospitals, adding to existing robotic orthopedic surgery capabilities. The da Vinci systems were installed about a month back, and management says it is too early to talk about traction.
• NABH Digital gold tier: All three hospitals were awarded the gold tier for NABH Digital Accreditation.
• Procedure-level metrics not tracked: Management does not track surgery or procedure-wise ARPOBs or department-wise ARPOBs very closely, so no granular data on robotic vs standard surgery pricing is available.

Doctor & Talent Model

• Very low doctor attrition: Attrition among doctors is in the very low single digits.
• No concrete retention formula disclosed: When asked what is being done differently to attract talent, management said it could not offer anything concrete on that front.

Guidance & Commitments

Key Metrics